Bioniq from UK raises €13.7M in Series B Funding to revolutionize Personalized Nutrition
London-based health tech startup Bioniq, known for creating personalized supplements based on blood biomarker data, has successfully closed a €13.7 million ($15 million) Series B funding round. This round, led by HV Capital and Unbound, brings Bioniq’s valuation to €68.73 million ($75 million).
London-based venture capital firm 13books Capital has announced the successful closure of a €144 million (£121 million) fund dedicated to fostering next-generation fintech disruptors. Despite a challenging fundraising environment, the fund has garnered substantial support from prominent backers including British Patient Capital, Kreditanstalt für Wiederaufbau (KfW), Isomer Capital, and IPGL.

The best Articles in our Network